Target intelligence / Profile preview

Cellular membrane phospholipid bilayer

Molecular classification
Lipid, Structural component, Membrane
01

Overview

The cellular membrane phospholipid bilayer is the fundamental structural matrix of all biological membranes, consisting of two layers of amphiphilic phospholipids with hydrophobic tails and hydrophilic heads (StatPearls, NBK555964). It serves as a critical semi-permeable barrier that maintains cellular homeostasis by regulating the transport of ions and molecules (NIH, Cell Membrane). In therapeutic contexts, the lipid bilayer is a primary target for several classes of anti-infective agents, such as polyene antifungals and lipopeptide antibiotics, which act by disrupting membrane integrity or forming lethal pores (PubMed, PMID: 25108313). Additionally, the composition and fluidity of the bilayer influence the function of embedded receptors and transporters, making it a site of action for various anesthetics and signaling modulators (PubMed, PMID: 18482075). Pathological changes in membrane lipid composition are associated with diseases like cancer and neurodegeneration, where altered membrane dynamics can drive disease progression (PubMed, PMID: 27039031).

Other names
Cell membrane phospholipidsLipid bilayerPlasma membraneBiological membranePhospholipid bilayer
02

Mechanism of action

Drugs targeting the lipid bilayer typically act through physical disruption of the membrane structure. This includes the formation of transmembrane pores (e.g., polyenes), detergent-like solubilization (e.g., polymyxins), or calcium-dependent insertion leading to rapid depolarization (e.g., daptomycin) (PubMed, PMID: 25108313). Some agents also alter membrane fluidity or thickness, indirectly modulating the activity of membrane-bound proteins (PubMed, PMID: 18482075).

03

Biological functions

Permeability barrierCellular compartmentalizationSignal transductionMembrane fluidityIon homeostasisProtein anchoring
04

Disease associations

InfectionCancerNeurodegenerative diseaseInflammationCardiovascular disease
05

Safety considerations

NephrotoxicityHemolysisNeurotoxicityLow therapeutic index due to poor selectivity between pathogen and host membranesInfusion-related reactions
06

Interacting drugs

Amphotericin B

8 more in the full profile.

07

Biomarkers

Phosphatidylserine exposureLipidomic profileMembrane potentialAnnexin V binding

Beyond the preview

Go deeper on Cellular membrane phospholipid bilayer.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular membrane phospholipid bilayer.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call